Biomaterials Science · 2022 · 30 citations · 36 references
PharmacyOncologyPharmaceuticsDrug DeliveryImmunotherapyTumor ImmunologyCancer Drug DeliveryCancer ImmunotherapyCombination ImmunotherapyHydrogelsImmunotherapy For Solid TumorsPhotothermal TherapyAntitumor Immune ActivationBiodegradabilityBiodegradable Photothermal AgentsCancer Photothermal TherapyCombination Photothermal TherapyInjectable GelsPhotothermal Conversion EfficiencyPower Density
and good photostability during five cycles. By further incorporation of R848, the obtained R848/POM@GG exerts synergetic photothermal-immunotherapy on solid tumors, giving a high tumor inhibition rate of 99.3% and negligible lung metastases in the breast cancer mice models. A strong antitumor immune system with significantly elevated TNF-α, IL-2, and IL-6 levels is activated by R848. Additionally, the POM clusters gradually degrade to nontoxic molybdate in the physiological environment. Overall, the injectable hydrogel platform of R848/POM@GG has great translational potential for localized antitumor treatments.
36
Jutaek Nam, Sejin Son, Lukasz J. Ochyl et al. · Nature Communications · 2018 · 807 citations · Full text
Medicine, Immunology, Oncology +17
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
Yuyan Jiang, Jiaguo Huang, Cheng Xu et al. · Nature Communications · 2021 · 435 citations · Full text
Life Sciences, Immunology, Oncology +17